Quick Answer
SPRUCE BIOSCIENCES, INC. reported Cash and Equivalents of $48.91 million for fiscal year 2025.
SPRUCE BIOSCIENCES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $48.91M | +26.2% |
| 2024 | $38.75M | -59.8% |
| 2023 | $96.34M | +293.4% |
| 2022 | $24.49M | -42.7% |
| 2021 | $42.75M | -72.8% |
| 2020 | $157.15M | +3904.8% |
| 2019 | $3.92M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.67M | -82.2% | -34.9% |
| June 30, 2025 | $16.39M | -76.5% | -36.0% |
| March 31, 2025 | $25.61M | -68.4% | -33.9% |
| December 31, 2024 | $38.75M | -59.8% | -35.5% |
| September 30, 2024 | $60.05M | -39.2% | -13.8% |
| June 30, 2024 | $69.68M | -28.5% | -14.1% |
| March 31, 2024 | $81.15M | +9.8% | -15.8% |
| December 31, 2023 | $96.34M | +293.4% | -2.5% |
- SPRUCE BIOSCIENCES, INC. showed an increase of +26.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, SPRUCE BIOSCIENCES, INC.’s cash and equivalents has grown by 1146.3% (from $3.92 million to $48.91 million).
- The most recent figure is from SPRUCE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: